Atlas FDA

Baxter ClearLink Intravenous (IV) Solution Sets and Extension Sets that have a ClearLink luer activated valve for IV acc

FDA device recall Z-0845-05 · posted 2005-05-17 · Terminated

Recall details

Recalling firm
Baxter Healthcare Corp.
Reason for recall
Possible occlusion of the Clearlink injection site valve due to inadequate silicone lubrication of the slit in the upper seal of the valve.
Action taken
Recall letters dated 2/28/05 were sent to the direct accounts via first class mail on the same date to the attention of the Director of Nursing. The accounts were informed of the increase in reports of ClearLink valve occlusion, requested to examine their inventory for the affected lots of product, and call Baxter Healthcare Center for Service at 1-888-229-001 to return the affected product for credit. The letters included a copy of the Technical Letter revised 5/4/04, outlining the correct preparation and use ClearLink valve product, including detecting valve re-knits.
Root cause
Other
Status
Terminated
Product code
FPA
Quantity affected
1,171,116 sets
Distribution
Nationwide, including Puerto Rico and American Samoa, and internationally to Canada, Panama, Australia, New Zealand and Venezuela.
Date initiated
2005-02-28
Date posted
2005-05-17
Date terminated
2007-02-08
Location
Round Lake, IL

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
SOLUTION ADMINISTRATION SETS WITH CAPLESS LUER ACTIVATED VALVE (K003225)Baxter Healthcare Corp2000-10-19
BURETROL SOLUTION SETS (K984381)Baxter Healthcare Corp1999-02-19
STOPCOCK MANIFOLD GANGS (K962581)Baxter Healthcare Corp1996-08-28
CONTINUFLO SOLUTION SET/SECONDARY MEDICATION SET (K961225)Baxter Healthcare Corp1996-06-21
LOW PLASTICIZER ADMINISTRATION SETS (K791496)Travenol Laboratories, S.A.1980-04-08